He is a pioneer in the field of nanogels and currently serves as an inside director of OncoLab. He was the doctoral advisor to OncoLab CEO Jongseong Kim during Jongseong’s time at the Georgia Institute of Technology. Now the Dean of the College of Engineering at Chapman University, he is an expert in hydrogel nanoparticles—the foundation of the ANGel platform—and actively collaborates with Jongseong Kim on the development of innovative medical devices and drug delivery systems utilizing hydrogel technologies.
He earned his Ph.D. in Chemistry from Georgia Institute of Technology and served as a postdoctoral researcher at Harvard University. Drawing from extensive foundational research experience in biophysics and physical chemistry, he is committed to ongoing research and development of ANGel platform and plans to incorporate artificial intelligence technology into future cancer treatments.
He received a bachelor’s degree in electrical engineering from Yonsei University and obtained a patent attorney qualification. He is actively involved in the patent field and currently serves as the Managing Partner of MUHANN Patent & Law Firm. Additionally, he oversees the establishment of IP-related strategies for OncoLab and manages related operations.
She earned her master’s degree in chemistry from Georgia Institute of Technology. With consulting experience in Boston, USA, and work experience in government agencies in South Korea, she oversees GLP and GMP operations at OncoLab.
She holds a master’s degree in Life Sciences from Konkuk University. Over the past five years, she has worked alongside CEO Jongseong Kim to develop ANGel platform and has completed the patent registration process. She is the lead author of a publication in the journal Advanced Healthcare Materials. Currently, she is practically responsible for preparing ANGel platform for GLP and GMP.
She completed an undergraduate degree in Trade at Kyungwon University and gained experience in accounting and finance. She is currently overseeing national projects and research administration at OncoLab.
She obtained a master's degree in pharmacy from Hanyang University and conducted research on the molecular mechanisms of cancer metastasis and anticancer drug resistance models. She is responsible for preclinical experiments for the ANGel platform at OncoLab and is involved in the R&D of new pipelines.
OncoLab is continuously hiring talented individuals in the field of biotechnology. Those interested in applying are encouraged to submit their documents via email.